6.00
price up icon6.38%   0.36
after-market Handel nachbörslich: 5.99 -0.010 -0.17%
loading
Schlusskurs vom Vortag:
$5.64
Offen:
$5.64
24-Stunden-Volumen:
1.14M
Relative Volume:
1.25
Marktkapitalisierung:
$524.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-95.90M
KGV:
-4.5455
EPS:
-1.32
Netto-Cashflow:
$-79.09M
1W Leistung:
+18.81%
1M Leistung:
+53.85%
6M Leistung:
+28.48%
1J Leistung:
-29.74%
1-Tages-Spanne:
Value
$5.55
$6.025
1-Wochen-Bereich:
Value
$5.07
$6.025
52-Wochen-Spanne:
Value
$1.865
$11.40

Terns Pharmaceuticals Inc Stock (TERN) Company Profile

Name
Firmenname
Terns Pharmaceuticals Inc
Name
Telefon
650-525-5535 EXT.101
Name
Adresse
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
Name
Mitarbeiter
59
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
TERN's Discussions on Twitter

Vergleichen Sie TERN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TERN
Terns Pharmaceuticals Inc
6.00 441.06M 0 -95.90M -79.09M -1.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-28 Eingeleitet William Blair Mkt Perform
2024-10-31 Eingeleitet Oppenheimer Outperform
2023-06-22 Eingeleitet Mizuho Buy
2023-06-07 Eingeleitet Jefferies Buy
2023-05-31 Eingeleitet ROTH MKM Buy
2023-05-08 Eingeleitet BMO Capital Markets Outperform
2023-02-14 Eingeleitet JMP Securities Mkt Outperform
2023-02-07 Eingeleitet UBS Buy
2022-09-12 Eingeleitet H.C. Wainwright Neutral
2021-09-14 Fortgesetzt Goldman Buy
2021-03-02 Eingeleitet Cowen Outperform
2021-03-02 Eingeleitet Goldman Buy
2021-03-02 Eingeleitet JP Morgan Overweight
Alle ansehen

Terns Pharmaceuticals Inc Aktie (TERN) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Terns Pharmaceuticals Inc. stockBreakthrough financial growth - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Terns Pharmaceuticals Inc. stock priceSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Terns Pharmaceuticals Inc. a good long term investmentFree Wealth Management Insights - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Terns Pharmaceuticals Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Terns Pharmaceuticals Inc. Stock Analysis and ForecastConsistently high yield - printweek.in

Jul 20, 2025
pulisher
Jul 18, 2025

What makes Terns Pharmaceuticals Inc. stock price move sharplyWeekly Big Movers - beatles.ru

Jul 18, 2025
pulisher
Jul 15, 2025

How Terns Pharmaceuticals Inc. stock performs during market volatilityPro Trader Stock Focus - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Terns Pharmaceuticals: A Catalyst-Driven Contrarian Play in Q4 2025 - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Terns Pharmaceuticals: A Risky Buy Ahead Of Q4 Obesity, Oncology Catalysts (NASDAQ:TERN) - Seeking Alpha

Jul 11, 2025
pulisher
Jul 10, 2025

Vontobel Holding Ltd. Buys Shares of 14,000 Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

Jul 09, 2025
pulisher
Jul 08, 2025

Terns Pharmaceuticals CEO & Director Acquires 98% More Stock - 富途牛牛

Jul 08, 2025
pulisher
Jun 30, 2025

CEO & Director of Terns Pharmaceuticals Picks Up 98% More Stock - simplywall.st

Jun 30, 2025
pulisher
Jun 25, 2025

Terns pharmaceuticals CEO Burroughs buys $90k in shares - Investing.com

Jun 25, 2025
pulisher
Jun 23, 2025

Terns Pharmaceuticals Presents Positive Data from Phase 1 - GlobeNewswire

Jun 23, 2025
pulisher
Jun 23, 2025

Terns completes enrollment in Phase 2 obesity drug trial - Investing.com

Jun 23, 2025
pulisher
Jun 18, 2025

Terns Pharmaceuticals’ SWOT analysis: promising pipeline faces competitive CML, obesity markets - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

SG Americas Securities LLC Purchases 380,489 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Analysts Set Terns Pharmaceuticals, Inc. (NASDAQ:TERN) PT at $15.63 - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Insider Buying: Andrew Gengos Acquires 15,000 Shares of Terns Pharmaceuticals Inc (TERN) - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Terns Pharmaceuticals Approves Directors and Accounting Firm - TipRanks

Jun 16, 2025
pulisher
Jun 11, 2025

3 Penny Stocks Wall Street Sees With 243% Upside - 24/7 Wall St.

Jun 11, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Has $73,000 Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Terns Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 04 - MarketScreener

Jun 10, 2025

Finanzdaten der Terns Pharmaceuticals Inc-Aktie (TERN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):